A detailed history of Wealth Dimensions Group, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Dimensions Group, Ltd. holds 3,177 shares of LLY stock, worth $2.83 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
3,177
Previous 3,242 2.0%
Holding current value
$2.83 Million
Previous $2.52 Million 14.04%
% of portfolio
0.82%
Previous 0.74%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $47,116 - $59,087
-65 Reduced 2.0%
3,177 $2.88 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $153,972 - $205,992
260 Added 8.72%
3,242 $2.52 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $268,897 - $316,994
-512 Reduced 14.65%
2,982 $1.74 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $7,824 - $10,787
-18 Reduced 0.51%
3,494 $1.88 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $122,759 - $164,143
350 Added 11.07%
3,512 $1.65 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $49,079 - $57,641
158 Added 5.26%
3,162 $1.09 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $22,830 - $26,601
-71 Reduced 2.31%
3,004 $1.1 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $18,085 - $20,610
61 Added 2.02%
3,075 $994,000
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $30,102 - $35,345
-108 Reduced 3.46%
3,014 $977,000
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $12,203 - $15,166
52 Added 1.69%
3,122 $894,000
Q4 2021

Feb 04, 2022

SELL
$224.85 - $279.04 $899 - $1,116
-4 Reduced 0.13%
3,070 $848,000
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $2,347 - $3,036
-13 Reduced 0.42%
3,074 $706,000
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $9,694 - $12,550
-59 Reduced 1.88%
3,087 $577,000
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $410,427 - $543,093
3,146 New
3,146 $531,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wealth Dimensions Group, Ltd. Portfolio

Follow Wealth Dimensions Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Dimensions Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Dimensions Group, Ltd. with notifications on news.